Table 3.
Primary outcome.
| Received capsaicin (n = 149) | Did not receive capsaicin (n = 52) | p | OR | 95% CI | β | |
|---|---|---|---|---|---|---|
| Primary outcome | ||||||
|
| ||||||
| Efficacy (requiring ≤1 additional doses of medication for symptom relief after capsaicin or first agent (control) prior to discharge) – No. (%) | 84 (55) | 11 (21) | <0.001 | 1.44 | 0.586–0.820 | |
|
| ||||||
| <21 and Received capsaicin (n = 17) | <21 did not receive capsaicin (n = 8) | P | OR | 95% CI | β | |
|
| ||||||
| Primary outcome | ||||||
| Efficacy in patients <21 years of age – No. (%) | 9 (53) | 3 (60) | 0.682 | 0.081–5.159 | −0.434 | |